Targeting oncofetal fibronectin and neuropilin-1 in solid tumors with PL2 peptide.

Lingasamy, Prakash et al.·Scientific reports·2025·
RPEP-121892025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Targeting oncofetal fibronectin and neuropilin-1 in solid tumors with PL2 peptide.
Published In:
Scientific reports, 15(1), 29369 (2025)
Database ID:
RPEP-12189

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-12189·https://rethinkpeptides.com/research/RPEP-12189

APA

Lingasamy, Prakash; Tobi, Allan; Kurm, Kaarel; Tammik, Olav; Teesalu, Tambet. (2025). Targeting oncofetal fibronectin and neuropilin-1 in solid tumors with PL2 peptide.. Scientific reports, 15(1), 29369. https://doi.org/10.1038/s41598-025-11299-x

MLA

Lingasamy, Prakash, et al. "Targeting oncofetal fibronectin and neuropilin-1 in solid tumors with PL2 peptide.." Scientific reports, 2025. https://doi.org/10.1038/s41598-025-11299-x

RethinkPeptides

RethinkPeptides Research Database. "Targeting oncofetal fibronectin and neuropilin-1 in solid tu..." RPEP-12189. Retrieved from https://rethinkpeptides.com/research/lingasamy-2025-targeting-oncofetal-fibronectin-and

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.